A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington's disease (2019)
Attributed to:
MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington's disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2019.10.260
Publication URI: http://dx.doi.org/10.1016/j.jns.2019.10.260
Type: Journal Article/Review
Parent Publication: Journal of the Neurological Sciences